Intended Use

The device is intended for radiation treatment planning for use in stereotactic, conformal, computer planned, Linac based radiation treatment and indicated for cranial, head and neck and extracranial lesions.

Technology

Software platform with multiple modules supporting radiation treatment planning using co-registered DICOM image sets from CT, MRI, PET. Includes AI/ML powered tumor segmentation trained on MRI data and dose optimization algorithms (Pencil Beam and Monte Carlo). Outputs DICOM RT dose plans for linear accelerator radiation therapy delivery.

Performance

The device underwent extensive performance testing including software verification, optimization algorithm comparison, dose calculation validation for accuracy with phantom measurements, validation of reference beam models, small field dose calculation, and AI tumor segmentation accuracy. The AI segmentation was validated on 595 scans from 412 patients across multiple clinical sites, showing good Dice scores (≥0.7) with high precision and recall for cranial tumors including metastases and meningiomas.

Predicate Devices

No predicate devices specified

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.